Skip to content

Advertisement

Open Peer Review Reports for: Innovative substance 2250 as a highly promising anti-neoplastic agent in malignant pancreatic carcinoma - in vitro and in vivo

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
1 Nov 2016 Submitted Original manuscript
10 Nov 2016 Author responded Author comments - Marie Buchholz
Resubmission - Version 2
10 Nov 2016 Submitted Manuscript version 2
15 Dec 2016 Reviewed Reviewer Report - Alexander Beatty
22 Dec 2016 Reviewed Reviewer Report - Linara Gabitova
20 Jan 2017 Author responded Author comments - Marie Buchholz
Resubmission - Version 3
20 Jan 2017 Submitted Manuscript version 3
9 Mar 2017 Author responded Author comments - Marie Buchholz
Resubmission - Version 4
9 Mar 2017 Submitted Manuscript version 4
Publishing
17 Mar 2017 Editorially accepted
24 Mar 2017 Article published 10.1186/s12885-017-3204-x

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement